EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link: https://ebookbell.com/faq

We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.

For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Alzheimers Disease And Related Disorders Annual 5 Serge Gauthier

Name: Alzheimers Disease And Related Disorders Annual 5 Serge Gauthier
SKU: BELL-2200114
Price: 31.00 USD
Availability: InStock
Rating: 4.7 (66 reviews)

SKU: BELL-2200114

$ 31.00 ~~$ 45.00~~ (-31%)

4.7

66 reviews

Alzheimers Disease And Related Disorders Annual 5 Serge Gauthier instant download after payment.

Publisher: Informa Healthcare

File Extension: PDF

File size: 1.45 MB

Pages: 226

Author: Serge Gauthier, Philip Scheltens, Jeffrey L. Cummings

ISBN: 9781435626379, 9781841845616

Language: English

Year: 2005

Product desciption

Alzheimers Disease And Related Disorders Annual 5 Serge Gauthier by Serge Gauthier, Philip Scheltens, Jeffrey L. Cummings 9781435626379, 9781841845616 instant download after payment.

This volume serves as a progress report on cutting-edge research in the field of Alzheimer's Disease and other forms of dementia, but with an emphasis on topics that are applicable to clinical practice. In this latest installment, Serge Gauthier, Philip Scheltens and Jeffrey Cummings cover some of the emerging therapies for Alzheimer's Disease, including statins, GAG minetics, and immunotherapy, as well as the use of hormonal therapy and atypical anti-psychotic agents in the treatment of other related dementias. Chapters will also summarize the current understanding of the pathophysiology of mild cognitive impairment as well as research into tau pathologies.